Oxymorphone Patch
Pain
PreclinicalActive
Key Facts
About Avecho Biotechnology
Australiancho leverages a vitamin‑E‑based delivery platform to boost efficacy and tolerability of diverse health products.
View full company profileTherapeutic Areas
Other Pain Drugs
| Drug | Company | Phase |
|---|---|---|
| Oxycodone Patch | Avecho Biotechnology | Preclinical |
| Desmetramadol | Syntrix Pharmaceuticals | Clinical Development |
| Diclofenac Potassium Powder for Oral Solution | Patrin Pharma | Approved |
| CG001419 | Cullgen | Phase 1 |
| Proprietary Pain Program(s) | Oblique Therapeutics | Pre-clinical |
| Pain Management APIs | Noramco | Commercial |
| Dipendium (Diclofenac Potassium) | NovaMedica | Approved |
| Na ion channel TicTACs | Solu Therapeutics | Preclinical |
| Infusional Pain Management (e.g., Paracetamol) | Galenica Senese | Commercial |
| NCEs for Pain Management | Ipca Laboratories | Preclinical/Discovery |
| XEN1701 | Xenon Pharmaceuticals | Phase 1 |